Magle Chemoswed Holding Ab
Research Magle Chemoswed Holding Ab (MAGLE) on Bullrun: market cap SEK 8.67M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMAGLE
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 8.67M
- Financial periodQ1 2026
- RevenueSEK 68.62M
- Net income-SEK 22.04M
- Free cash flow-SEK 7.73M
- Gross margin87.7%
Valuation Snapshot
latest market cap is SEK 8.67M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 282.92M | -SEK 159.89M | -SEK 63.82M | 82.2% | -7.76 | SEK 13.59M | SEK 346.19M | SEK 395.84M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | SEK 8.67M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Magle Chemoswed Holding Ab
Magle Chemoswed Holding AB (publ) engages in researching, developing, and manufacturing in the areas of medicinal chemistry and pharmaceutical technology in Sweden, Switzerland, rest of Europe, the United States, Brazil, and internationally. It offers degradable starch microsphere and dextran products; and active pharmaceutical ingredients, as well as engages in the research, development, manufacture, market, and sale of diagnostics products to hospitals, clinics, and pharmacies;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Magle Chemoswed Holding Ab's market cap?
Magle Chemoswed Holding Ab's market capitalization is SEK 8.67M.
What does Magle Chemoswed Holding Ab do?
Magle Chemoswed Holding AB (publ) engages in researching, developing, and manufacturing in the areas of medicinal chemistry and pharmaceutical technology in Sweden, Switzerland, rest of Europe, the United States, Brazil, and internationally. It offers degradable starch microsphere and dextran products; and active pharmaceutical ingredients, as well as engages in the research, development, manufacture, market, and sale of diagnostics products to hospitals, clinics, and pharmacies; and contract development and manufacturing organization activities.